Compare AIRI & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIRI | BMRA |
|---|---|---|
| Founded | 1979 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3M | 11.5M |
| IPO Year | 2013 | 1995 |
| Metric | AIRI | BMRA |
|---|---|---|
| Price | $2.65 | $2.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.3K | ★ 32.3K |
| Earning Date | 11-13-2026 | 10-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 24.39 | ★ 39.81 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $47,921,000.00 | $4,453,000.00 |
| Revenue This Year | $4.34 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.30 | $1.45 |
| 52 Week High | $3.95 | $3.21 |
| Indicator | AIRI | BMRA |
|---|---|---|
| Relative Strength Index (RSI) | 45.88 | N/A |
| Support Level | $2.55 | N/A |
| Resistance Level | $2.76 | N/A |
| Average True Range (ATR) | 0.08 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 26.77 | 0.00 |
Air Industries Group is an aerospace and defense company. Its manufacturers of precision components and assemblies for large aerospace and defense prime contractors. The company products include landing gears, flight controls, engine mounts and components for aircraft jet engines, ground turbines and other complex machines. The ultimate end-user of products is the U.S. Government, international governments, and commercial global airlines.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.